Or Kalchiem-Dekel, MD
Interventional Pulmonologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Lung Nodules
- Robotic Bronchoscopy
- Endobronchial Ultrasound (EBUS)
Request an Appointment
About Me
- Assistant Attending
I am an interventional pulmonologist specializing in minimally invasive procedures to diagnose and treat cancers and other ailments involving the chest, such as lung complications related to cancer treatment. This includes:
- Bronchoscopy procedures using a robotic, flexible, or rigid bronchoscope
- Procedures to diagnose and treat pleural effusions (the buildup of fluid between the tissue that lines the lung and chest cavity), such as pleuroscopy, placement of pleural catheters, and chemical pleurodesis.
My special interest and research focus is in the field of robotic-assisted bronchoscopy. I am interested in using this innovative technology to develop and implement new ways to effectively and safely biopsy and treat cancerous lung lesions.
An interventional pulmonologist (IN-ter-VEN-shun-al pull-muh-NAHL-uh-jist) is a doctor with special training in treating lung problems, such as blocked airways, cancer, and tumors.
My Specialties
- Lung Nodules
- Robotic Bronchoscopy
- Endobronchial Ultrasound (EBUS)
- Airway Tumor Ablation
- Airway Stents
- Endobronchial Valves
- Pleural Effusion Management
- Pleuroscopy
- Percutaneous Tracheostomy
Education
- MD, Ben-Gurion University of the Negev, Israel
Residencies
- Internal Medicine - Soroka University Medical Center, Israel
Awards and Honors
- Award Recipient, Annual Respiratory Young Investigators’ Forum (2019)
- Best Basic Science Research Award Recipient, Metropolitan DC Thoracic Society Annual Meeting (2019)
- Award Recipient, American College of Chest Physicians Asthma Fellows Conference (2017)
Fellowships
- Pulmonary and Critical Care Medicine, University of Maryland Medical Center, Baltimore, MD
- Advanced Pulmonary and Critical Care Medicine - Academic Research Track, National Institutes of Health, Bethesda, MD
- Interventional Pulmonology - Memorial Sloan Kettering Cancer Center
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, HMO
MSK has a tentative agreement with Cigna to continue coverage in 2024.
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Kalchiem-Dekel sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Kalchiem-Dekel O, Tran BC, Glick DR, Ha NT, Iacono A, Pickering EM, Shah NG, Sperry MG, Sachdeva A, Reed RM. Prophylactic epinephrine attenuates severe bleeding in lung transplantation patients undergoing transbronchial lung biopsy: Results of the PROPHET randomized trial. J Heart Lung Transplant. 2023 Sep;42(9):1205-1213. doi: 10.1016/j.healun.2023.03.007. Epub 2023 Mar 14.PMID: 37140517 Clinical Trial.
Kalchiem-Dekel O, Falcon CJ, Bestvina CM, Liu D, Kaplanis LA, Wilhelm C, Eichholz J, Harada G, Wirth LJ, Digumarthy SR, Lee RP, Kadosh D, Mendelsohn RB, Donington J, Gainor JF, Drilon A, Lin JJ. Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy. J Thorac Oncol. 2022 Jul 1:S1556-0864(22)00312-4. doi: 10.1016/j.jtho.2022.06.008. Online ahead of print. PMID: 35788405
Kalchiem-Dekel O, Connolly JG, Lin IH, Husta BC, Adusumilli PS, Beattie JA, Buonocore DJ, Dycoco J, Fuentes P, Jones DR, Lee RP, Park BJ, Rocco G, Chawla M, Bott MJ. Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions. Chest. 2021 Aug 9:S0012-3692(21)03625-4. doi: 10.1016/j.chest.2021.07.2169. Online ahead of print.PMID: 34384789
Read more
Kalchiem-Dekel O, Fuentes P, Bott MJ, Beattie JA, Lee RP, Chawla M, Husta BC. Multiplanar 3D fluoroscopy redefines tool-lesion relationship during robotic-assisted bronchoscopy. Respirology. 2021 Jan;26(1):120-123. doi: 10.1111/resp.13966. Epub 2020 Nov 2.PMID: 33140495
Kalchiem-Dekel O, Schwalk AJ, Patel NM, Lin IH, Beattie JA, Husta BC, Chawla M, Sachdeva A, Akulian JA, Musani AI, Argento AC, Lee HJ, Mullon JJ, Desai NR, Hsia DW, Lee RP. COVID-19 Impact on Interventional Pulmonology Training. ATS Sch. 2021 Apr 13;2(2):236-248. doi: 10.34197/ats-scholar.2020-0126OC. eCollection 2021 Jun.PMID: 34409418
Kalchiem-Dekel O, Yao X, Barochia AV, Kaler M, Figueroa DM, Karkowsky WB, Gordon EM, Gao M, Fergusson MM, Qu X, Liu P, Li Y, Seifuddin F, Pirooznia M, Levine SJ. Apolipoprotein E Signals via TLR4 to Induce CXCL5 Secretion by Asthmatic Airway Epithelial Cells. Am J Respir Cell Mol Biol. 2020 Aug;63(2):185-197. doi: 10.1165/rcmb.2019-0209OC. PMID: 32338995; PMCID: PMC7397770.
Kalchiem-Dekel O, Hines SE. Forty years of reference values for respiratory system impedance in adults: 1977-2017. Respir Med. 2018 Mar;136:37-47. doi: 10.1016/j.rmed.2018.01.015. Epub 2018 Jan 31. PMID: 29501245.
Kalchiem-Dekel O, Yao X, Levine SJ. Meeting the Challenge of Identifying New Treatments for Type 2-Low Neutrophilic Asthma. Chest. 2020 Jan;157(1):26-33. doi: 10.1016/j.chest.2019.08.2192. Epub 2019 Sep 13. PMID: 31525357; PMCID: PMC6965689.
Kalchiem-Dekel O, Iacono A, Pickering EM, Sachdeva A, Shah NG, Sperry M, Tran BC, Reed RM. Prophylactic epinephrine for the prevention of transbronchial lung biopsy-related bleeding in lung transplant recipients (PROPHET) study: a protocol for a multicentre randomised, double-blind, placebo-controlled trial. BMJ Open. 2019 Mar 23;9(3):e024521. doi: 10.1136/bmjopen-2018-024521. PMID: 30904852; PMCID: PMC6475255.
Kalchiem-Dekel O, Iacono A, Pickering EM, Sachdeva A, Shah NG, Sperry M, Tran BC, Reed RM. Prophylactic epinephrine for the prevention of transbronchial lung biopsy-related bleeding in lung transplant recipients (PROPHET) study: a protocol for a multicentre randomised, double-blind, placebo-controlled trial. BMJ Open. 2019 Mar 23;9(3):e024521. doi: 10.1136/bmjopen-2018-024521. PMID: 30904852; PMCID: PMC6475255.
Kalchiem-Dekel O, Shanholtz CB, Jeudy J, Sachdeva A, Pickering EM. Feasibility, safety, and utility of bronchoscopy in patients with ARDS while in the prone position. Crit Care. 2018 Mar 2;22(1):54. doi: 10.1186/s13054-018-1983-3. PMID: 29499729; PMCID: PMC5834861.
Gavish R, Levy A, Dekel OK, Karp E, Maimon N. The Association Between Hospital Readmission and Pulmonologist Follow-up Visits in Patients With COPD. Chest. 2015 Aug;148(2):375-381. doi: 10.1378/chest.14-1453. PMID: 25611698.
Avnon L, Kalchiem-Dekel O, Gozlan-Talmor A, Shimonovitch F, Shalev R, Maimon N. [THE ROLE OF CLOSED PLEURAL BIOPSY IN THE DIAGNOSIS OF TUBERCULOUS PLEURISY IN A POPULATION AT-RISK]. Harefuah. 2016 Feb;155(2):110-4, 130-1. Hebrew. PMID: 27215124.
Patient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Or Kalchiem-Dekel discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].